Skip to content

A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females

A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females - A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034963
Enrollment
120
Registered
2018-11-23
Start date
2018-12-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy people

Interventions

Intake of the test food (2 capsules/day, 12 weeks) Intake of control food (2 capsules/day, 12 weeks)

Sponsors

KT Medical Corporation
Lead Sponsor
Department of Dermatology, Wakayama Medical University
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Japanese adult female aged from 30 to 54 years old at time of informed consent was provided

Exclusion criteria

Exclusion criteria: 1) Individuals who use regularly cosmetology or food affecting the skin condition 2) Individuals who have skin disease, or whose skin have an abnormality requiring treatment, or who have disease with affecting skin condition 3) Individuals who need to wear masks or to blow their nose due to allergic rhinitis or individuals who maybe develop the allergy during the study 4) Individuals who have chronic disease 5) Individuals with serious disorders or individuals with histories of serious disorders 6) Individuals who excessively take alcohol 7) Individuals who is smoker (smoking over 20 cigarettes/day) 8) Individuals who have a history of serious drug allergy or serious food allergy 9) Individuals who are pregnant or Individuals who are willing to become pregnant or lactation during this study 10) Individuals who are participating in other clinical trials or individuals who participated in other clinical trials within 1 month 11) Any Individuals considered to be unsuitable for enrollment in the opinion of the principal investigator

Design outcomes

Primary

MeasureTime frame
Index for skin conditions (Skin moisuture content, Transepidermal water loss, Skin viscoelasticity)

Secondary

MeasureTime frame
Observation for skin condition Collagen Score (measuring with ultrasonic waves) Subjective symptoms for skin condition (VAS) POMS

Countries

Japan

Contacts

Public ContactShigeru Imai

KT Medical Corporation Food clinical trial division

imai@kt-medical.co.jp03-6667-0345

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026